Shares of Eli Lilly have gained considerably throughout 2024, thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity in ...
Eli Lilly has seen revenue soar thanks to its blockbuster weight loss drug portfolio. Lilly and Novo Nordisk dominate this market, which has seen high demand. Eli Lilly (NYSE: LLY) stock recently ...
Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily outperforming both the S&P 500 and Nasdaq Composite indexes. Much of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback